OTTAWA – The maker of a popular heartburn medication is halting distribution amid concerns of a cancer-causing chemical.
Sandoz, the makers of Zantac made the decision days after regulators in the U.S. and Europe found NDMA, a known carcinogen, in the medications.
— GovCanHealth (@GovCanHealth) September 18, 2019
The chemical was found in brand name and generic forms of Zantac, which the key ingredient is Ranitidine.
The company also issued a recall for Canada for the following products: Sandoz Ranitidine 150 mg tablet and 300 mg tablet.
Health Canada is also asking all companies to stop distribution of the medicine.